Submitted:
17 October 2024
Posted:
18 October 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. Surgical Technique
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021, 71, 209–249. [Google Scholar] [CrossRef] [PubMed]
- Mártha, O.; Balan, D.; Porav-Hodade, D.; Drágus, E.; Vartolomei, M.D.; Chibelean, C.B.; et al. The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer. Rev. Romana Med. Lab. 2020, 28, 29–38. [Google Scholar] [CrossRef]
- Antoni, S.; Ferlay, J.; Soerjomataram, I.; Znaor, A.; Jemal, A.; Bray, F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur. Urol. 2017, 71, 96–108. [Google Scholar] [CrossRef] [PubMed]
- Teoh, J.Y.C.; Huang, J.; Ko, W.Y.K.; Lok, V.; Choi, P.; Ng, C.F.; Borda, A.; Pytel, *!!! REPLACE !!!*; Vida, O. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita. Eur. Urol. 2020, 78, 893–906. [Google Scholar] [CrossRef]
- Wong, M.C.S.; Fung, F.D.H.; Leung, C.; Cheung, W.W.L.; Goggins, W.B.; Ng, C.F. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci. Rep. 2018, 8, 1129. [Google Scholar] [CrossRef]
- Burger, M.; Catto, J.W.F.; Dalbagni, G.; Grossman, H.B.; Herr, H.; Karakiewicz, P.; Kassouf, W.; Kiemeney, L.A.; La Vecchia, C.; Shariat, S.; et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 2013, 63, 234–241. [Google Scholar] [CrossRef]
- Alfred Witjes, J.; Max Bruins, H.; Carrión, A.; Cathomas, R.; Compérat, E.; Efstathiou, J.A.; Kassouf, W.; Kiemeney, L.A.; La Vecchia, C.; Shariat, S.; et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur Urol. 2024, 85, 17–31. [Google Scholar] [CrossRef]
- Babjuk, M.; Burger, M.; Capoun, O.; Cohen, D.; Compérat, E.M.; Dominguez Escrig, J.L.; Kassouf, W.; Kiemeney, L.A.; La Vecchia, C.; Shariat, S.; et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). Eur. Urol. 2022, 81, 75–94. [Google Scholar] [CrossRef]
- Holzbeierlein, J.; Bixler, B.R.; Buckley, D.I.; Chang, S.S.; Holmes, R.S.; James, A.C.; Kassouf, W.; Kiemeney, L.A.; La Vecchia, C.; Shariat, S. ;. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J. Urol. 2024, 212, 3–10. [Google Scholar] [CrossRef]
- Aminoltejari, K.; Black, P.C. Radical cystectomy: a review of techniques, developments and controversies. Transl. Androl. Urol. 2020, 9, 3073–3081. [Google Scholar] [CrossRef]
- De Nunzio, C.; Cicione, A.; Leonardo, F.; Rondoni, M.; Franco, G.; Cantiani, A.; Kassouf, W.; Kiemeney, L.A.; La Vecchia, C.; Shariat, S. ;. Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians. Int. Urol. Nephrol. 2011, 43, 663–667. [Google Scholar] [CrossRef] [PubMed]
- You, C.; Li, Q.; Yang, Y.; Qing, L.; Liu, S.; Wang, Y.; Kassouf, W.; Kiemeney, L.A.; La Vecchia, C.; Shariat, S. ;. Extraperitoneal Versus Intraperitoneal Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. Ann. Surg. Oncol. 2023, 30, 5932–5941. [Google Scholar] [CrossRef] [PubMed]
- Robinson, T.N.; Eiseman, B.; Wallace, J.I.; Church, S.D.; McFann, K.K.; Pfister, S.M.; Sharp, T.J.; Moss, M. Redefining Geriatric Preoperative Assessment Using Frailty, Disability and Co-Morbidity. Ann. Surg. 2009, 250, 449–455. [Google Scholar] [CrossRef] [PubMed]
- Sathianathen, N.J.; Jarosek, S.; Lawrentschuk, N.; Bolton, D.; Konety, B.R. A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy. Eur. Urol. Focus. 2019, 5, 658–663. [Google Scholar] [CrossRef]
- Dindo, D.; Demartines, N.; Clavien, P.A. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef]
- Zhang, Y.; Rumgay, H.; Li, M.; Yu, H.; Pan, H.; Ni, J. The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040. J Glob Health 2023, 13, 04109. [Google Scholar] [CrossRef]
- Premo, C.; Apolo, A.B.; Agarwal, P.K.; Citrin, D.E. Trimodality Therapy in Bladder Cancer. Urol. Clin. N. Am. 2015, 42, 169–180. [Google Scholar] [CrossRef]
- Shabsigh, A.; Korets, R.; Vora, K.C.; Brooks, C.M.; Cronin, A.M.; Savage, C.; Raj, G.; Bochner, B.H.; Dalbagni, G.; Herr, H.W.; et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur. Urol. 2009, 55, 164–174. [Google Scholar] [CrossRef]
- Leonardo, K.; Mirza, H.; Seno, D.H.; Purnomo, N.; Afriansyah, A.; Siregar, M.A.R. Transperitoneal vs extraperitoneal radical cystectomy: A systematic review and meta-analysis. Awedew AF, editor. PLoS ONE 2023, 18, e0294809. [Google Scholar] [CrossRef]
- Kulkarni, J.N.; Agarwal, H. Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study. Int. Braz. J. Urol. 2018, 44, 296–303. [Google Scholar]
- Zhang, Y.; Zhou, H.; Tuo, Z.T.; Wang, J.; Sun, C.; Bi, L. Extraperitoneal laparoscopic radical cystectomy with intracorporeal neobladder: a comparison with transperitoneal approach. World J. Surg. Onc. 2022, 20, 130. [Google Scholar] [CrossRef] [PubMed]
- Kulkarni, J.N.; Gulla, R.I.; Tongaonkar, H.B.; Kashyapi, B.D.; Rajyaguru, K.B. Radical cystoprostatectomy: an extraperitoneal retrograde approach. J. Urol. 1999, 161, 545–548. [Google Scholar] [CrossRef] [PubMed]
- Özkaptan, O.; Çubuk, A.; Dinçer, E.; Şahan, A.; Kafkaslí, A.; Akça, O. Extraperitoneal Antegrade vs Transperitoneal Open Radical Cystectomy: Single Center Experiences with 200 Cases. BLC 2020, 6, 187–194. [Google Scholar] [CrossRef]
- Soleimani, M.; Moradkhani, E.; Masoumi, N.; Gholivandan, J. Extra-Peritoneal versus Trans-Peritoneal Open Radical Cystectomy - Comparison of Two Techniques in Early Post-Operative Complications. Urol. J. 2020, 2019, 6147. [Google Scholar]
- Jentzmik, F.; Schostak, M.; Stephan, C.; Baumunk, D.; Lingnau, A.; Weikert, S.; Sharp, T.J.; Moss, M. Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique. World J. Urol. 2010, 28, 457–463. [Google Scholar] [CrossRef]
- Roth, B.; Birkhäuser, F.D.; Zehnder, P.; Burkhard, F.C.; Thalmann, G.N.; Studer, U.E. Readaptation of the Peritoneum Following Extended Pelvic Lymphadenectomy and Cystectomy Has a Significant Beneficial Impact on Early Postoperative Recovery and Complications: Results of a Prospective Randomized Trial. Eur. Urol. 2011, 59, 204–210. [Google Scholar] [CrossRef]
- Van Der Vlies, E.; Los, M.; Stijns, P.E.F.; Van Hengel, M.; Blaauw, N.M.S.; Bos, W.J.W.; Sharp, T.J.; Moss, M. Preoperative frailty and outcome in patients undergoing radical cystectomy. BJU Int. 2020, 126, 388–395. [Google Scholar] [CrossRef]
- Novara, G.; Catto, J.W.F.; Wilson, T.; Annerstedt, M.; Chan, K.; Murphy, D.G.; Sharp, T.J.; Moss, M.; et al. Systematic Review and Cumulative Analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Cystectomy. Eur. Urol. 2015, 67, 376–401. [Google Scholar] [CrossRef]
- Lauridsen, S.V.; Tønnesen, H.; Jensen, B.T.; Neuner, B.; Thind, P.; Thomsen, T. Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis of four RCTs. Syst. Rev. 2017, 6, 150. [Google Scholar] [CrossRef]
- Jerlström, T.; Gårdmark, T.; Carringer, M.; Holmäng, S.; Liedberg, F.; Hosseini, A.; Malmström, P.-U.; Ljungberg, B.; Hagberg, O.; Jahnson, S. Urinary bladder cancer treated with radical cystectomy: Perioperative parameters and early complications prospectively registered in a national population-based database. Scand. J. Urol. 2014, 48, 334–340. [Google Scholar] [CrossRef]
- De Nunzio, C.; Cicione, A.; Izquierdo, L.; Lombardo, R.; Tema, G.; Lotrecchiano, G.; Minervini, A.; Simone, G.; Cindolo, L.; D’orta, C.; et al. Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index. Clin. Genitourin. Cancer 2019, 17, 402–407. [Google Scholar] [CrossRef] [PubMed]
| Variable | Value |
|---|---|
| Age at surgery [years], median (range) | 77 (59-84) |
| Males, n (%) | 61 (81.3) |
| Females, n (%) | 14 (18,7) |
| BMI [kg/m2], median (range) | 26 (17-35) |
| Obstructive renal failure, n (%) | 20 (26.7) |
| Moderate-severe anemia, n (%) | 35 (46.7) |
| Hypoalbuminemia, n (%) | 33 (44.0) |
| ASA score | |
| ASA 2, n (%) | 24 |
| ASA 3, n (%) | 47 |
| ASA 4 n (%) | 4 |
| Variable | Value |
|---|---|
| Median operative time [minutes], median (range) | 150 (90-210) |
| Median blood loss [mL], median (range) | 400 (200-1500) |
| Median time to flatus [days], median (range) | 2 (1-7) |
| Blood transfusion, n (%) | 23 (30) |
| Urinary diversion | |
| Cutaneous ureterostomy, n (%) | 65 (86.7) |
| Ileal conduit, n (%) | 10 (13.3) |
| Intraoperative incidents | |
| Rectal injury, n (%) | 1 (1.3) |
| External iliac vein injury, n (%) | 1 (1.3) |
| Obturatory nerve injury, n (%) | 1 (1.3) |
| Postoperative complication | |
| Clavien III, n (%) | 11 (14.7) |
| Clavien IV, n (%) | 2 (2.7) |
| Clavien V, n (%) | 2 (2.7) |
| Duration of postoperative hospital stay [days], median (range) | 7 (5-14) |
| Variable | Value |
|---|---|
| Pathological T stage | |
| pT2, n (%) | 48 (64) |
| pT3, n (%) | 23 (30,7) |
| pT4, n (%) | 4 (5,3) |
| Pathological N stage | |
| Lymph node dissection, n (%) | 60 (80) |
| pN0, n (%) | 45 (60) |
| pN1, n (%) | 12 (18) |
| pN2, n (%) | 3 (4,4) |
| Concomitant prostate adenocarcinoma | 15 (20.0) |
| Positive surgical margins, n (%) | 1 (1.3) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).